View |
2019-10-25-0273
|
Inactivated Poliomyelitis Vaccine (Types 1, 2 and 3)
|
Imovax Polio
|
BR-929
|
R3N66
|
Packaging Lot - Box:R3N661V; Vial: R3N66, MD: 02122018, ED: 11-2021
|
30 November 2021
|
30 October 2019
|
View |
2019-12-03-0299
|
Tetanus Toxoid (Adsorbed)
|
T-Vac
|
BR-326
|
2598A005C
|
Packaging lot (box and ampoule): 2598A005C
|
30 November 2021
|
05 December 2019
|
View |
2020-01-16-0012
|
Inactivated Poliomyelitis Vaccine (Types 1, 2 and 3)
|
Imovax Polio
|
BR-929
|
R3N90
|
Packaging Lot - Box:R3N901V; Vial: R3N90, MD: 23122018, ED: 11-2021
|
30 November 2021
|
20 January 2020
|
View |
2020-01-16-0013
|
Inactivated Poliomyelitis Vaccine (Types 1, 2 and 3)
|
Imovax Polio
|
BR-929
|
R3P21
|
Packaging Lot - Box:R3P211V; Vial: R3P21, MD: 27122018, ED: 11-2021
|
30 November 2021
|
20 January 2020
|
View |
2020-02-20-0043
|
Equine Anti-Rabies Immunoglobulin
|
Vinrab
|
BR-678
|
08AR19015
|
Packaging Lot:
08AR19015
|
30 November 2021
|
24 February 2020
|
View |
2020-03-30-0073
|
Inactivated Poliomyelitis Vaccine (Type 1, 2 and 3)
|
Imovax Polio
|
BR-929
|
R3P31
|
Packaging Lot: Box - R3P311V; Vial - R3P31
|
30 November 2021
|
30 March 2020
|
View |
2020-06-08-0161
|
Tetanus Toxoid (Adsorbed)
|
T-Vac
|
BR-326
|
2598A005A
|
Packaging Lot (box & vial): 2598A005A
|
30 November 2021
|
15 June 2020
|
View |
2021-03-29-0125
|
QUADRIVALENT SEASONAL INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) SOUTHERN HEMISPHERE 2021 STRAIN
|
FLUARIX TETRA
|
BR-1125
|
AFLBA532A
|
Packaging Lot (Box & Pre-filled Syringe): AFLBA532AB
Needle (25G x 1"): 2008034; Needle (25G x 5/8"): 2005033
|
30 November 2021
|
30 March 2021
|
View |
2021-03-31-0130
|
QUADRIVALENT SEASONAL INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) SOUTHERN HEMISPHERE 2021 STRAIN
|
FLUARIX TETRA
|
BR-1125
|
AFLBA535B
|
Packaging Lot (Box and PFS): AFLBA535BB
Needle (25G x 1"): 2008035; Needle (25G x 5/8"): 2005034
|
30 November 2021
|
05 April 2021
|
View |
2020-03-30-0074
|
Typhoid Vaccine (Purified Vi-capsular Polysaccharide of Salmonella typhi Ty2)
|
Typbar
|
BR-827
|
54D19010A
|
Packaging lot: 54D19010A, MD: 12/19, ED: 11/22; Needle: 1811005 ED: 2023-1031
|
30 November 2022
|
30 March 2020
|
View |
2020-03-30-0075
|
Typhoid Vaccine (Purified Vi-capsular Polysaccharide of Salmonella typhi Ty2)
|
Typbar
|
BR-827
|
54D19011A
|
Packaging lot: 54D19011A, MD: 12/19, ED: 11/22; Needle: 1811005 ED: 2023-1031
|
30 November 2022
|
30 March 2020
|
View |
2020-03-30-0076
|
Typhoid Vaccine (Purified Vi-capsular Polysaccharide of Salmonella typhi Ty2)
|
Typbar
|
BR-827
|
54D19009A
|
Packaging lot: 54D19009A, MD: 12/19, ED: 11/22 ; Needle: 1811005 ED: 2023-1031
|
30 November 2022
|
30 March 2020
|
View |
2020-06-19-0169
|
Tetanus Toxoid
|
Bio-TT
|
BR-663
|
281519
|
Packaging Lot-box: 0281519, MD: NOV 25, 19, ED: NOV 22; Ampoule: 0281519, ED: NOV 22
|
30 November 2022
|
22 June 2020
|
View |
2020-06-19-0170
|
Tetanus Toxoid
|
Bio-TT
|
BR-663
|
281419
|
Packaging Lot-box: 0281419, MD: NOV 22, 19, ED: NOV 22; Ampoule: 0281419, ED: NOV 22
|
30 November 2022
|
22 June 2020
|
View |
2020-06-19-0171
|
Tetanus Toxoid
|
Bio-TT
|
BR-663
|
281319
|
Packaging Lot-box: 0281319, MD: NOV 21, 19, ED: NOV 22; Ampoule: 0281319, ED: NOV 22
|
30 November 2022
|
22 June 2020
|
View |
2021-02-10-0056
|
BIPHASIC ISOPHANE INSULIN (rDNA ORIGIN)
|
GLYSOLIN 30/70
|
BRP-034-01
|
DV11053
|
Packaging Lot (Box & Vial): DV11053
|
30 November 2022
|
31 March 2021
|
View |
2021-02-10-0060
|
Inactivated Poliomyelitis Vaccine (Type 1, 2 and 3)
|
IMOVAX POLIO
|
BR-929
|
T3M82
|
Packaging Lot (Box): T3M821V; (Vial): T3M82
|
30 November 2022
|
15 February 2021
|
View |
2021-03-04-0102
|
Erenumab
|
AERINEX
|
BR-1313
|
1126630
|
Packaging Lot (Box & Pre-filled Syringe): 1126630
|
30 November 2022
|
05 March 2021
|
View |
2021-04-22-0164
|
PERTUZUMAB
|
PERJETA
|
BR-927
|
H0476
|
Packaging Lot (Box): H0476B22R1; (Vial): H0476
|
30 November 2022
|
27 April 2021
|
View |
2021-04-28-0188
|
ERENUMAB
|
AERINEX
|
BR-1313
|
1129999
|
Packaging Lot (Box & Pre-filled syringe): 1129999
|
30 November 2022
|
30 April 2021
|